Stay updated on ENABLE Study: Lanadelumab in HAE Clinical Trial

Sign up to get notified when there's something new on the ENABLE Study: Lanadelumab in HAE Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the ENABLE Study: Lanadelumab in HAE Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    7 days ago
    Change Detected
    Summary
    The footer’s ClinicalTrials.gov revision label changes from v3.7.2 to v3.8.0.
    Difference
    0.1%
    Check dated 2026-10-31T13:45:37.000Z thumbnail image
  3. Check
    14 days ago
    Change Detected
    Summary
    A site-wide NIH notice announces a transition in terminology from “Artificial Intelligence” to “Super Intelligence” and links to related updates and FAQs.
    Difference
    0.8%
    Check dated 2026-10-24T14:15:07.000Z thumbnail image
  4. Check
    21 days ago
    Change Detected
    Summary
    The site footer now displays revision v3.7.2 instead of v3.7.1.
    Difference
    0.1%
    Check dated 2026-10-17T14:13:04.000Z thumbnail image
  5. Check
    28 days ago
    Change Detected
    Summary
    The footer’s ClinicalTrials.gov revision number changes from v3.7.0 to v3.7.1.
    Difference
    0.1%
    Check dated 2026-10-10T15:15:47.000Z thumbnail image
  6. Check
    49 days ago
    Change Detected
    Summary
    A new revision v3.7.0 was added to the history to reflect a metadata update, and the previous revision v3.6.6 was removed from the visible history.
    Difference
    0.1%
    Check dated 2026-09-19T18:21:37.000Z thumbnail image
  7. Check
    70 days ago
    Change Detected
    Summary
    A new revision label v3.6.6 was added to the study's history and the previous v3.6.5 label was removed. This update affects the revision metadata shown in the record history rather than substantive study content.
    Difference
    0.1%
    Check dated 2026-08-29T20:00:44.000Z thumbnail image

Stay in the know with updates to ENABLE Study: Lanadelumab in HAE Clinical Trial

Enter your email address, and we'll notify you when there's something new on the ENABLE Study: Lanadelumab in HAE Clinical Trial page.